Indexed with PubMed and Science Citation Index (E) 
Users online: 3245 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (712 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded76    
    Comments [Add]    

Recommend this journal


 Table of Contents    
Year : 2013  |  Volume : 79  |  Issue : 2  |  Page : 247-248

Using blue gel pen to mark freckles during Q-switched laser therapy

Laser Center, Plastic Surgery Hospital, Peking Union Medical College, Beijing, China

Date of Web Publication22-Feb-2013

Correspondence Address:
Meng-hua Huo
No. 33, Road Badachu, Beijing - 100 144
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.107652

Rights and Permissions

How to cite this article:
Liu Xj, Huo Mh. Using blue gel pen to mark freckles during Q-switched laser therapy. Indian J Dermatol Venereol Leprol 2013;79:247-8

How to cite this URL:
Liu Xj, Huo Mh. Using blue gel pen to mark freckles during Q-switched laser therapy. Indian J Dermatol Venereol Leprol [serial online] 2013 [cited 2020 Jun 4];79:247-8. Available from: http://www.ijdvl.com/text.asp?2013/79/2/247/107652


Freckles, one of the common benign pigmented skin lesions, are small brown macules that appear on sun-exposed areas. [1] When requested for cosmetic purposes, the three Q-switched lasers (532 nm Nd:YAG, 694 nm ruby, and 755 nm Alexandrite) can be used to treat these lesions with excellent results. [2] The mechanism of Q-switched laser is based on the selective photothermolysis, [3] whereby selective absorption of high-power laser pulses causes selective removal of the abnormal pigment cells or vessels, without damaging other structures and without scarring.

During Q-switched laser irradiation, the localization of the macules is very important in treating the entirety of the macules appropriately, including smaller and lighter ones. When the practitioner wears laser safety glasses during treatment, the exact location of the macules can be difficult to visualize, especially in the smaller or lighter ones and insufficient light. In addition, as the laser treatment proceeds, there is often reactive vasodilatation, which can obscure the nearby untreated macules. A useful technique using a blue gel pen to mark freckles for Q-switched laser treatment is described.

Before Q-switched laser irradiation, all freckles' location, including smaller and lighter macules, is exactly marked by a blue gel pen (M and G Tough Gel VGP-1220 0.5 mm blue pen, M and G Stationery Inc., Shanghai, China) without laser safety glasses. During laser irradiation, the blue gel is easily and totally disappear from the macules' surface into the air by Q-switched laser microexplosion without increasing superficial cutaneous injury [Figure 1].
Figure 1: Freckles (a), after marking (b) with a blue gel pen and treatment (c) using a Q-switched laser

Click here to view

The technique can also be used to mark the margin of other pigmented lesions, such as lentigines, Café au lait spot, and nevus of Ota during Q-switched laser treatment.

  References Top

1.Polder KD, Landau JM, Vergilis-Kalner IJ, Goldberg LH, Friedman PM, Bruce S. Laser eradication of pigmented lesions: A review. Dermatol Surg 2011;37:572-95.  Back to cited text no. 1
2.Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol 1993;19:376-9.  Back to cited text no. 2
3.Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.  Back to cited text no. 3


  [Figure 1]


Print this article  Email this article


Online since 15th March '04
Published by Wolters Kluwer - Medknow